Checkmate Pharmaceuticals
Developing a new approach for cancer immunotherapy.
Employees
Enterprise value
$340—510m
loading funding rounds…
F-Prime(exited)
Sofinnova Partners(exited)
venBio Partners(exited)
Sofinnova(exited)
Decheng Capital(exited)
Longitude Capital(exited)
Novo Holdings(exited)
Medicxi(exited)
Omega Funds(exited)
Clough Capital Partners(exited)
Sectoral Asset Management(exited)
BrightEdge(exited)
Eight Roads Ventures(exited)
Novo Seeds(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.